Related Experiment Videos
Structural identification of prostaglandin A1 biotransformation products from tumor cells
B Vulliez-Le Normand1, A Gouyette, V Heidet
1INSERM U 207, Institut Pasteur, URIA, Paris, France.
Abstract:
Rat B104 neuroblastoma and C6 glioma cells are able to metabolize prostaglandin A1 (PGA1). Four metabolites were isolated by high performance liquid chromatography. Their structure was elucidated by fast atom bombardment mass spectrometry and 1H nuclear magnetic resonance. It appears that these biotransformation products are two sets of stereoisomers: the two isomers that eluted first are 9 alpha- and 9 beta-hydroxy-11 alpha-cysteinylglycyl adducts whereas the other two are 9 alpha- and 9 beta-hydroxy-11 alpha-cysteinyl derivatives. These compounds were compared with authentic samples prepared by Michael addition of the corresponding thiol onto PGA1, then by reduction with sodium borohydride.
Insights
Rat neuroblastoma and glioma cells metabolize prostaglandin A1 (PGA1), forming novel cysteinyl adducts and derivatives. These biotransformation products represent two sets of stereoisomers, expanding our understanding of prostaglandin metabolism.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Prostaglandins, like Prostaglandin A1 (PGA1), are biologically active lipids involved in various physiological processes.
- Understanding the metabolic pathways of prostaglandins is crucial for elucidating their function and potential therapeutic applications.
- Specific cell types, such as neuroblastoma and glioma cells, may possess unique enzymatic machinery for prostaglandin metabolism.
Purpose of the Study:
- To investigate the metabolic fate of Prostaglandin A1 (PGA1) in rat B104 neuroblastoma and C6 glioma cell lines.
- To identify and characterize the metabolites produced from PGA1 biotransformation.
- To elucidate the stereochemistry of the identified PGA1 metabolites.
Main Methods:
- Incubation of rat B104 neuroblastoma and C6 glioma cells with Prostaglandin A1 (PGA1).
- Isolation and purification of metabolites using high-performance liquid chromatography (HPLC).
- Structural elucidation of metabolites via fast atom bombardment mass spectrometry (FAB-MS) and 1H nuclear magnetic resonance (NMR) spectroscopy.
- Synthesis of authentic standards using Michael addition of thiols to PGA1, followed by sodium borohydride reduction.
Main Results:
- Four distinct metabolites of PGA1 were successfully isolated and characterized.
- The identified metabolites comprise two sets of stereoisomers: 9 alpha- and 9 beta-hydroxy-11 alpha-cysteinylglycyl adducts, and 9 alpha- and 9 beta-hydroxy-11 alpha-cysteinyl derivatives.
- Comparison with synthetically prepared authentic samples confirmed the structures of the biotransformation products.
Conclusions:
- Rat B104 neuroblastoma and C6 glioma cells possess the enzymatic capacity to metabolize Prostaglandin A1 (PGA1).
- The biotransformation yields novel cysteinylglycyl adducts and cysteinyl derivatives, existing as stereoisomeric pairs.
- These findings contribute to the understanding of prostaglandin metabolism in neural-derived cell lines and highlight the formation of complex adducts.